Novavax's Prototype Vaccine Shows Broad Immune Responses Inc

WASHINGTON (dpa-AFX) - Novavax Inc.'s (NVAX) prototype vaccine (NVX-CoV2373) demonstrated broad immune responses including against Omicron and other circulating variants. Pre-clinical data demonstrated

Related Keywords

Washington , United States , , Drug Administration Vaccines , Products Advisory Committee , Novavax Inc , Related Biological Products Advisory Committee , Emergency Use Authorization , Novavax , Prototype , Vaccine , Shows , Road , Immune , Responses , Fncl , Against , Micron , Mother , Variants ,